Floatz logo

Recombinant Vaccinia Gm-Csf; Rac Vac Gm-Csf

Carcinoma, Colorectal

Jennerex BiotherapeuticsPhase 2Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

161 Active assets in the Carcinoma, Colorectal cohort.

Asset / SponsorPhaseRating
TIPIRACIL
Mayo Clinic
Phase 2BBB
FLUOROURACILUM
City of Hope Medical Center
Phase 4BB
Eloxatin
First Affiliated Hospital of Zhejiang University
Phase 4BB
MITOMYCIN C
City of Hope Medical Center
Phase 3BB
Capecitabine
First Affiliated Hospital of Zhejiang University
Phase 4BB

View all 50 →

Same molecule, other indications

Recombinant Vaccinia Gm-Csf; Rac Vac Gm-Csf is also rated in:

head and neck squamous cell carcinomaDormant
CC
Indicative ·
47 / 100
View asset →
Wilms tumorDormant
CC
Indicative ·
47 / 100
View asset →
Ewing sarcomaDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →